DOCSLIB.ORG

Acne Vulgaris - Onset Acne Vulgaris • Lesions May Begin As Early As 8-10 Years • Incidence Increases Steadily During Adolescence Mkabhtlmdmark A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acne Vulgaris - Onset Acne Vulgaris • Lesions May Begin As Early As 8-10 Years • Incidence Increases Steadily During Adolescence Mkabhtlmdmark A Acne Vulgaris - Onset Acne Vulgaris • Lesions may begin as early as 8-10 years • Incidence increases steadily during adolescence MkABhtlMDMark A. Bechtel, M.D. • Girls often develop acne earlier than boys Director of Dermatology • Severe acne affects boys 10 times more The Ohio State University College of Medicine frequently than girls • Severe cystic acne may have a family history Acne Vulgaris Patients at Increased Risk for Developing Acne • A multifactorial disorder of the pilosebaceous unit • XYY chromosomal phenotype • Affects 40-50 million individuals each year in the U .S . • Polycystic ovarian syndrome • Peak incidence occurs during adolescence • Hyperandrogenism • May create self-consciousness and social • Hypercortisolism isolation • Precocious puberty • Affects 85% of young people 12-24 years of age 1 Principal Factors in the Pathogenesis of Acne Pathogenesis of Acne • The formation of the microcomedone is the • Increased sebum production initial step in development of acne • Abnormal keratinization of the follicular • The microcomedo begins in keratinized epithelium lining of the upper portion of the pilosebaceous follicule, the infundibulum. • Proliferation of propionibacterium acnes • Retention and accumulation of corneocytes • inflammation produces hyperkeratosis in the proximal infundibulum of the pilosebaceous lumen Propionibacterium acnes Acne Lesions • Gram-positive, non-motile rod, anaerobic • Non inflammatory lesions 9 Closed comedo (whitehead) • Naturally produces porphyrins (Coproporphyrin III), which fluoresces with 9 Open comedo (blackhead) a Woods light • Inflammatory lesions • Plays a role in production of lipases, 9 Papules enzymes that contribute to comedo rupture 9 Pustules and production of several proinflammatory 9 Cysts mediators. 9 Abscesses • Activates Toll-like receptor 2 (TLR2). 2 3 Neonatal Acne Infantile Acne • Occurs in more than 20% of healthy • Presents at 3-6 months of age newborns • Comedo formation more prominent • Lesions appear at about 2 weeks of age and us uall y resolve b y 3 months • Cystic acne and scarring may occur • Malassezia furfur (yeast organism) may be • Reflects hormonal imbalances intrinsic to the etiology stage of development of infant • Inflamed papules over nose and cheeks • Infant boys – elevated LH and testosterone • May improve with ketoconazole cream • Infant boys and girls – elevated DHEA Acne Fulminans • The most severe form of cystic acne • Primarily young men 13-16 years of age • Painful cysts, hemorrhagic crusts, severe scarring • Osteolytic bone lesions, fever, arthralgias, myalgias, enlarged liver-spleen • Isotretinoin, systemic and intralesional steroids, Dapsone 4 Acne Mechanica • Occurs secondary to repeated mechanical and frictional obstruction of the pilosebaceous outlet • Comedo formation results • Rubbing of helmets, chin straps, collars Acne Conglobata • Severe nodulocystic acne without systemic manifestations • Part of the follicu lar occlu sion tetrad – dissecting cellulitis of scalp, hidradenitis suppurativa, and pilonidal cysts • Isotretinoin, systemic and intralesional steroids 5 Acne Excoriée • Comedones and inflammatory papules are neurotically excoriated • Patients develop crusted erosions that scar • Many patients have an underlying psychiatric component, anxiety disorder, or obsessive-compulsive disorder • Antidepressants or psychotherapy may be beneficial. Drug-induced Acne • Anabolic steroids • Corticosteroids • Phenytoin • Lithium • Isoniazid • Iodides • Bromides • Inhibitors of epidermal growth factor receptor (EGFR) 6 Occupational Acne Chloracne • Follicle-occluding substances in the • Occupational acne caused by exposure to workplace chlorinated aromatic hydrocarbons • Cutting oils, petroleum-based products, coal tar derivatives, chlorinated aromatic hydrocarbons Basic Objectives of Acne Therapy • Reduction of sebum output • Reduction of bacterial numbers • Alteration of cell adherence • Alteration of abnormal keratinization • Reduction of inflammation 7 Management of Acne Topical Antibiotics • Topical therapies • Systemic therapies • Bacteriostatic effect on P. acnes 9 Benzoyl peroxides 9 Oral antibiotics • Anti-inflammatory effects 9 Topical antibiotics 9 Isotretinoin • Bacterial resistance may occur with monotherapy 9 Topical retinoids 9 Oral contraceptives • Topical agents include erythromycin, 9 Salicylic acid 9 Spironolactone clindamycin, sodium sulfacetamide, and sulfur 9 Azelaic acid products 9 Topical Dapsone • Preparations available as gels, solutions, 9 Combination topicals pledgets, and combined with benzoyl peroxide Combination Antibiotics Benzoyl Peroxides and Benzoyl Peroxides • Potent bactericidal effect • Decreases number of P. acnes and FFA • Benzoyl peroxides have been combined • Due to lack of bacterial resistance, should be an with erythromycin and clindamycin integral part of acne therapy • Combining benzoyl peroxide with • May decrease size and number of comedones erythromycin or clindamycin greatly • Side effect include contact sensitivity and reduces bacterial resistance to the bleaching of clothes antibiotic component • Formulations include washes, gels, soap bars, and combinations with topical antibiotics 8 Topical Retinoids Adapalene (Differin®) • May help normalize follicular keratinization • Increase epidermal cell turnover and decreases • A derivative of naphthoic acid cell cohesiveness • Receptor specific (RAR-gamma) • Inhibits formation of comedones and helps expel • Product is not degraded by sunlight and existing comedones can be applied at same time as benzoyl • Minimal risk of tetratogenicity peroxide • Caution with sunlight exposure • May be less irritating and have less • May enhance penetration of co-administered comedolytic activity than tretinoin medication into the sebaceous follicule • May have anti-inflammatory effects • Available as gel and cream Tretinoin – Retin A®, Avita® Tazarotene (Tazorac®) • First topical retinoid – all trans-retinoic acid • A synthetic acetylenic retinoid • Product is photolabile – apply at night • Receptor specific for RAR-beta and RAR • May cause a pustular flare during initial 3-4 gamma weeks • Category X – avoid in pregnancy • Most common side effects are topical irritation and increased risk of sunburn • Light stable • Available in gels, creams, solutions, and • Skin irritation most common side effect microspheres impregnated with tretinoin • Available as cream or gel 9 Azelaic Acid (Azelex®, Finacea®) Commonly used oral antibiotics in the treatment of acne • Dicarboxcylic acid derivative • Antimicrobial, anti-inflammatory, and • Tetracycline comedolyyytic activity • DliDoxycycline • May help decrease post-inflammatory hyperpigmentation • Minocycline • More effective when combined with other • Erythromycin topicals Other oral antibiotics used Oral Antibiotics in acne treatment • Suppress the growth of P. acnes • Trimethoprim-sulfamethoxazole • With decrease in P. acnes, the FFA levels fall • Trimethoprim • Cephalosporins • Interfere with local chemical and cellular inflammatory mechanisms • Ampicillin • Tetracycline, erythromycin, and • Azithromycin clindamycin inhibit neutrophil chemotaxis • Clindamycin 10 Spironolactone Isotretinoin (Accutane®, Sotret®) • Blocks binding of androgens to androgen • 13-cis retinoic acid receptors • Indicated for severe nodulocystic acne • Recalcitrant acne in adult women refractory to conventional treatment • Avoid during pregnancy due to effects on • Exact mechanism of action is not known, male genitalia but the drug does act on sebaceous glands • May cause menstrual irregularities, breast and reduces sebum production by 90% tenderness, and hyperkalemia • Reduction in P. acnes and normalization of • Combine with birth control pill follicular keratinization Side Effects of Oral Antibiotics Isotretinoin • Minocycline – pseudotumor cerebri, blue discoloration of skin and teeth, vertigo, drug • Dosing varies from 0.5 – 2.0 mg/kg/day for induced lupus, immune hepatitis 16-20 weeks • Doxycycline – photosensitivity and epigastric discomfort • Risk of relapse is reduced if cumulative • Tetracycline – GI irritation, candidal vaginitis, dose reaches 120-150 mg/kg enamel changes in patients under 10 • Approximately 40% of patients relapse • Erythromycin – GI upset, hepatotoxicity • Caution when starting in patients with • Clindamycin – pseudomembranous colitis severe inflammatory acne • Trimeth-sulfa – TEN, neutropenia, aplastic anemia, liver toxicity 11 Isotretinoin Side Effects • Teratogenic in humans – pregnancy prevention critical • Possible association with depression and suicide • Xerosis, chelitis, alopecia, dry eyes, muscle aches, epistaxis • Pseudotumor cerebri, hepatotoxicity, hypertriglyceridemia, vertebral hyperostosis 12 FDA Advisory Panel on Isotretinoin Endocrine Abnormalities and Acne-Hyperandrogenism • Suspect in female patients with severe acne, • Proposed a new risk management program hirsutism, irregular menstrual periods, and androgenetic alopecia • Previous risk management programs did • May be associated with insulin resistance and not significantly reduce pregnancies acanthosis nigricans • Initial tests (off oral contraceptives) include total and free testosterone, DHEAS, and 17- hydroxyprogesterone • If hypercortisolism is suspected, obtain a morning serum cortisol level. Isotretinoin Pregnancy Risk Abnormal Endocrine Labs Management Program (IPRMP) • Congenital adrenal hyperplasia • All interested parties have obligations 9 DHEAS levels 4000-8000 ng/ml 9 Wholesalers • Adrenal tumor 9 Pharmacy 9 DHEAS
Load more

Recommended publications
  • Herb Lotions to Regrow Hair in Patients with Intractable Alopecia Areata Hideo Nakayama*, Ko-Ron Chen Meguro Chen Dermatology Clinic, Tokyo, Japan
    Clinical and Medical Investigations Research Article ISSN: 2398-5763 Herb lotions to regrow hair in patients with intractable alopecia areata Hideo Nakayama*, Ko-Ron Chen Meguro Chen Dermatology Clinic, Tokyo, Japan Abstract The history of herbal medicine in China goes back more than 1,000 years. Many kinds of mixtures of herbs that are effective to diseases or symptoms have been transmitted from the middle ages to today under names such as Traditional Chinese Medicine (TCM) in China and Kampo in Japan. For the treatment of severe and intractable alopecia areata, such as alopecia universalis, totalis, diffusa etc., herb lotions are known to be effective in hair regrowth. Laiso®, Fukisin® in Japan and 101® in China are such effective examples. As to treat such cases, systemic usage of corticosteroid hormones are surely effective, however, considering their side effects, long term usage should be refrained. There are also these who should refrain such as small children, and patients with peptic ulcers, chronic infections and osteoporosis. AL-8 and AL-4 were the prescriptions removing herbs which are not allowed in Japanese Pharmacological regulations from 101, and salvia miltiorrhiza radix (SMR) is the most effective herb for hair growth, also the causation to produce contact sensitization. Therefore, the mechanism of hair growth of these herb lotions in which the rate of effectiveness was in average 64.8% on 54 severe intractable cases of alopecia areata, was very similar to DNCB and SADBE. The most recommended way of developing herb lotion with high ability of hairgrowth is to use SMR but its concentration should not exceed 2%, and when sensitization occurs, the lotion should be changed to Laiso® or Fukisin®, which do not contain SMR.
    [Show full text]
  • Acne in Childhood: an Update Wendy Kim, DO; and Anthony J
    FEATURE Acne in Childhood: An Update Wendy Kim, DO; and Anthony J. Mancini, MD cne is the most common chron- ic skin disease affecting chil- A dren and adolescents, with an 85% prevalence rate among those aged 12 to 24 years.1 However, recent data suggest a younger age of onset is com- mon and that teenagers only comprise 36.5% of patients with acne.2,3 This ar- ticle provides an overview of acne, its pathophysiology, and contemporary classification; reviews treatment op- tions; and reviews recently published algorithms for treating acne of differing levels of severity. Acne can be classified based on le- sion type (morphology) and the age All images courtesy of Anthony J. Mancini, MD. group affected.4 The contemporary Figure 1. Comedonal acne. This patient has numerous closed comedones (ie, “whiteheads”). classification of acne based on sev- eral recent reviews is addressed below. Acne lesions (see Table 1, page 419) can be divided into noninflammatory lesions (open and closed comedones, see Figure 1) and inflammatory lesions (papules, pustules, and nodules, see Figure 2). The comedone begins with Wendy Kim, DO, is Assistant Professor of In- ternal Medicine and Pediatrics, Division of Der- matology, Loyola University Medical Center, Chicago. Anthony J. Mancini, MD, is Professor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children’s Hospital of Chi- cago. Address correspondence to: Anthony J. Man- Figure 2. Moderate mixed acne. In this patient, a combination of closed comedones, inflammatory pap- ules, and pustules can be seen. cini, MD, Division of Dermatology Box #107, Ann and Robert H.
    [Show full text]
  • Table S1. Checklist for Documentation of Google Trends Research
    Table S1. Checklist for Documentation of Google Trends research. Modified from Nuti et al. Section/Topic Checklist item Search Variables Access Date 11 February 2021 Time Period From January 2004 to 31 December 2019. Query Category All query categories were used Region Worldwide Countries with Low Search Excluded Volume Search Input Non-adjusted „Abrasion”, „Blister”, „Cafe au lait spots”, „Cellulite”, „Comedo”, „Dandruff”, „Eczema”, „Erythema”, „Eschar”, „Freckle”, „Hair loss”, „Hair loss pattern”, „Hiperpigmentation”, „Hives”, „Itch”, „Liver spots”, „Melanocytic nevus”, „Melasma”, „Nevus”, „Nodule”, „Papilloma”, „Papule”, „Perspiration”, „Petechia”, „Pustule”, „Scar”, „Skin fissure”, „Skin rash”, „Skin tag”, „Skin ulcer”, „Stretch marks”, „Telangiectasia”, „Vesicle”, „Wart”, „Xeroderma” Adjusted Topics: "Scar" + „Abrasion” / „Blister” / „Cafe au lait spots” / „Cellulite” / „Comedo” / „Dandruff” / „Eczema” / „Erythema” / „Eschar” / „Freckle” / „Hair loss” / „Hair loss pattern” / „Hiperpigmentation” / „Hives” / „Itch” / „Liver spots” / „Melanocytic nevus” / „Melasma” / „Nevus” / „Nodule” / „Papilloma” / „Papule” / „Perspiration” / „Petechia” / „Pustule” / „Skin fissure” / „Skin rash” / „Skin tag” / „Skin ulcer” / „Stretch marks” / „Telangiectasia” / „Vesicle” / „Wart” / „Xeroderma” Rationale for Search Strategy For Search Input The searched topics are related to dermatologic complaints. Because Google Trends enables to compare only five inputs at once we compared relative search volume of all topics with topic „Scar” (adjusted data). Therefore,
    [Show full text]
  • Copyrighted Material
    1 Index Note: Page numbers in italics refer to figures, those in bold refer to tables and boxes. References are to pages within chapters, thus 58.10 is page 10 of Chapter 58. A definition 87.2 congenital ichthyoses 65.38–9 differential diagnosis 90.62 A fibres 85.1, 85.2 dermatomyositis association 88.21 discoid lupus erythematosus occupational 90.56–9 α-adrenoceptor agonists 106.8 differential diagnosis 87.5 treatment 89.41 chemical origin 130.10–12 abacavir disease course 87.5 hand eczema treatment 39.18 clinical features 90.58 drug eruptions 31.18 drug-induced 87.4 hidradenitis suppurativa management definition 90.56 HLA allele association 12.5 endocrine disorder skin signs 149.10, 92.10 differential diagnosis 90.57 hypersensitivity 119.6 149.11 keratitis–ichthyosis–deafness syndrome epidemiology 90.58 pharmacological hypersensitivity 31.10– epidemiology 87.3 treatment 65.32 investigations 90.58–9 11 familial 87.4 keratoacanthoma treatment 142.36 management 90.59 ABCA12 gene mutations 65.7 familial partial lipodystrophy neutral lipid storage disease with papular elastorrhexis differential ABCC6 gene mutations 72.27, 72.30 association 74.2 ichthyosis treatment 65.33 diagnosis 96.30 ABCC11 gene mutations 94.16 generalized 87.4 pityriasis rubra pilaris treatment 36.5, penile 111.19 abdominal wall, lymphoedema 105.20–1 genital 111.27 36.6 photodynamic therapy 22.7 ABHD5 gene mutations 65.32 HIV infection 31.12 psoriasis pomade 90.17 abrasions, sports injuries 123.16 investigations 87.5 generalized pustular 35.37 prepubertal 90.59–64 Abrikossoff
    [Show full text]
  • Acne and Rosacea in Skin of Color Heather Woolery-Lloyd, MD; Erica Good, BA
    Editorial Acne and Rosacea in Skin of Color Heather Woolery-Lloyd, MD; Erica Good, BA reatment of acne in skin of color poses unique of ethnicities, including African Americans, Asians, challenges. Postinflammatory hyperpigmentation Hispanics/Latinos, Pacific Islanders, Middle Easterners, T is a common complaint and must be addressed in and Native Americans, patients with skin of color cur- this patient population. Although less common in skin rently represent 34% of the US population. As it is of color, rosacea can often be more severe in this patient estimated that this figure will rise to 47% by 2050, it is population. We will review acne and rosacea in patients important to have a thorough understanding of how acne with skin of color and will focus on management of the presents in this patient population in order to optimize concerns unique to this patient population. their treatment.3 Regardless of skin color, acne remains the most com- monly diagnosed dermatologic condition. Studies have Clinical Characteristics reported an overall incidence as high as 29% in black Papules are the most frequent presentation of acne in patients, with similar figures for white patients in com- skin of color, occurring in 70.7% of African American parative studies.1 In adult women alone, the prevalence patients and 74.5% of Hispanics/Latinos. Acne hyperpig- may exceedCOS 50%.2 DERMmented maculae are also a common presenting feature, Postinflammatory hyperpigmentation presents a occurring in 65% of African Americans and in 48% of unique but common challenge when treating acne in skin Hispanic/Latino women with acne, according to a recent of color, and can often become a greater source of distress study (Figure 1).4,5 Among African Americans, other com- to the patient than the acne itself.
    [Show full text]
  • Environmental Health Criteria 242
    INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY Environmental Health Criteria 242 DERMAL EXPOSURE IOMC INTER-ORGANIZATION PROGRAMME FOR THE SOUND MANAGEMENT OF CHEMICALS A cooperative agreement among FAO, ILO, UNDP, UNEP, UNIDO, UNITAR, WHO, World Bank and OECD This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the World Health Organization The International Programme on Chemical Safety (IPCS) was established in 1980. The overall objec- tives of the IPCS are to establish the scientific basis for assessment of the risk to human health and the environment from exposure to chemicals, through international peer review processes, as a prerequi- site for the promotion of chemical safety, and to provide technical assistance in strengthening national capacities for the sound management of chemicals. This publication was developed in the IOMC context. The contents do not necessarily reflect the views or stated policies of individual IOMC Participating Organizations. The Inter-Organization Programme for the Sound Management of Chemicals (IOMC) was established in 1995 following recommendations made by the 1992 UN Conference on Environment and Development to strengthen cooperation and increase international coordination in the field of chemical safety. The Participating Organizations are: FAO, ILO, UNDP, UNEP, UNIDO, UNITAR, WHO, World Bank and OECD. The purpose of the IOMC is to promote coordination of the policies and activities pursued by the Participating Organizations, jointly or separately, to achieve the sound management of chemicals in relation to human health and the environment. WHO Library Cataloguing-in-Publication Data Dermal exposure. (Environmental health criteria ; 242) 1.Hazardous Substances - poisoning.
    [Show full text]
  • Acne and Related Conditions
    Rosanne Paul, DO Madeline Tarrillion, DO Miesha Merati, DO Gregory Delost, DO Emily Shelley, DO Jenifer R. Lloyd, DO, FAAD American Osteopathic College of Dermatology Disclosures • We do not have any relevant disclosures. Cleveland before June 2016 Cleveland after June 2016 Overview • Acne Vulgaris • Folliculitis & other – Pathogenesis follicular disorders – Clinical Features • Variants – Treatments • Rosacea – Pathogenesis – Classification & clinical features • Rosacea-like disorders – Treatment Acne vulgaris • Pathogenesis • Multifactorial • Genetics – role remains uncertain • Sebum – hormonal stimulation • Comedo • Inflammatory response • Propionibacterium acnes • Hormonal influences • Diet Bolognia et al. Dermatology. 2012. Acne vulgaris • Clinical Features • Face & upper trunk • Non-inflammatory lesions • Open & closed comedones • Inflammatory lesions • Pustules, nodules & cysts • Post-inflammatory hyperpigmentation • Scarring • Pitted or hypertrophic Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Acne variants • Acne fulminans • Acne conglobata • PAPA syndrome • Solid facial edema • Acne mechanica • Acne excoriée • Drug-induced Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Acne variants • Occupational • Chloracne • Neonatal acne (neonatal cephalic pustulosis) • Infantile acne • Endocrinological abnormalities • Apert syndrome Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Acne variants • Acneiform
    [Show full text]
  • 12.2% 116000 125M Top 1% 154 4300
    We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists 4,300 116,000 125M Open access books available International authors and editors Downloads Our authors are among the 154 TOP 1% 12.2% Countries delivered to most cited scientists Contributors from top 500 universities Selection of our books indexed in the Book Citation Index in Web of Science™ Core Collection (BKCI) Interested in publishing with us? Contact [email protected] Numbers displayed above are based on latest data collected. For more information visit www.intechopen.com ProvisionalChapter chapter 4 Occupational Acne Occupational Acne Betul Demir and Demet Cicek Betul Demir and Demet Cicek Additional information is available at the end of the chapter Additional information is available at the end of the chapter http://dx.doi.org/10.5772/64905 Abstract Occupational and environmental acne is a dermatological disorder associated with industrial exposure. Polyhalogenated hydrocarbons, coal tar and products, petrol, and other physical, chemical, and environmental agents are suggested to play a role in the etiology of occupational acne. The people working in the field of machine, chemistry, and electrical industry are at high risk. The various occupational acne includes chloracne, coal tar, and oil acne. The most common type in clinic is the comedones, and it is also seen as papule, pustule, and cystic lesions. Histopathological examination shows epidermal hyperplasia, while follicular and sebaceous glands are replaced by keratinized epidermal cells. Topical or oral retinoic acids and oral antibiotics could be used in treatment. The improvement in working conditions, taking preventive measures, and education of the workers could eliminate occupational acne as a problem.
    [Show full text]
  • Tissue Liver X-Receptor Alpha (Lxrα) Level in Acne Vulgaris
    TISSUE LIVER X-RECEPTOR ALPHA (LXRα) LEVEL IN ACNE VULGARIS Thesis Submitted for the fulfillment of Master Degree in Dermatology and Venereology BY Eman Abdelhamed Aly Nada (M.B.B.Ch) Supervisors Dr. Shereen Osama Tawfic Assistant prof.of Dermatology Faculty of Medicine Cairo University Dr. Marwa Ahmed Ezzat Lecturer of Dermatology Faculty of Medicine Cairo University Dr. Olfat Gamil Shaker Professor of Medical Biochemistry Faculty of Medicine Cairo University Faculty of Medicine Cairo University 2012 1 Acknowledgment First and foremost, I am thankful to God, for without his help I could not finish this work. I would like to express my sincere gratitude and appreciation to Dr. Shereen Osama Tawfic, Assistant Professor of Dermatology, Faculty of Medicine, Cairo University, for giving me the honor for working under her supervision and for her great support and stimulating views. Special thanks and deepest gratitude to Dr. Marwa Ahmed Ezzat, Lecturer of Dermatology, Faculty of Medicine, Cairo University, for her advice, support and encouragement all the time for a better performance. I am deeply thankful to Prof. Dr. Olfat Gamil Shaker, Professor of Medical Biochemistry, Faculty of Medicine, Cairo University for her sincere scientific and moral help in accomplishing the practical part of this study. I would like to extend my warmest gratitude to Prof. Dr. Manal Abdelwahed Bosseila, Professor of Dermatology, Faculty of Medicine, Cairo University, whose hard and faithful efforts have helped me to do this work. Furthermore, I would like to thank my family who stood behind me to finish this work and for their great support to me.
    [Show full text]
  • Management of Acne
    Review CMAJ Management of acne John Kraft MD, Anatoli Freiman MD cne vulgaris has a substantial impact on a patient’s Key points quality of life, affecting both self-esteem and psychoso- cial development.1 Patients and physicians are faced • Effective therapies for acne target one or more pathways A in the pathogenesis of acne, and combination therapy with many over-the-counter and prescription acne treatments, gives better results than monotherapy. and choosing the most effective therapy can be confusing. • Topical therapies are the standard of care for mild to In this article, we outline a practical approach to managing moderate acne. acne. We focus on the assessment of acne, use of topical • Systemic therapies are usually reserved for moderate or treatments and the role of systemic therapy in treating acne. severe acne, with a response to oral antibiotics taking up Acne is an inflammatory disorder of pilosebaceous units to six weeks. and is prevalent in adolescence. The characteristic lesions are • Hormonal therapies provide effective second-line open (black) and closed (white) comedones, inflammatory treatment in women with acne, regardless of the presence papules, pustules, nodules and cysts, which may lead to scar- or absence of androgen excess. ring and pigmentary changes (Figures 1 to 4). The pathogene- sis of acne is multifactorial and includes abnormal follicular keratinization, increased production of sebum secondary to ing and follicle-stimulating hormone levels.5 Pelvic ultra- hyperandrogenism, proliferation of Propionibacterium acnes sonography may show the presence of polycystic ovaries.5 In and inflammation.2,3 prepubertal children with acne, signs of hyperandrogenism Lesions occur primarily on the face, neck, upper back and include early-onset accelerated growth, pubic or axillary hair, chest.4 When assessing the severity of the acne, one needs to body odour, genital maturation and advanced bone age.
    [Show full text]
  • Acneiform Dermatoses
    Dermatology 1998;196:102–107 G. Plewig T. Jansen Acneiform Dermatoses Department of Dermatology, Ludwig Maximilians University of Munich, Germany Key Words Abstract Acneiform dermatoses Acneiform dermatoses are follicular eruptions. The initial lesion is inflamma- Drug-induced acne tory, usually a papule or pustule. Comedones are later secondary lesions, a Bodybuilding acne sequel to encapsulation and healing of the primary abscess. The earliest histo- Gram-negative folliculitis logical event is spongiosis, followed by a break in the follicular epithelium. The Acne necrotica spilled follicular contents provokes a nonspecific lymphocytic and neutrophilic Acne aestivalis infiltrate. Acneiform eruptions are almost always drug induced. Important clues are sudden onset within days, widespread involvement, unusual locations (fore- arm, buttocks), occurrence beyond acne age, monomorphous lesions, sometimes signs of systemic drug toxicity with fever and malaise, clearing of inflammatory lesions after the drug is stopped, sometimes leaving secondary comedones. Other cutaneous eruptions that may superficially resemble acne vulgaris but that are not thought to be related to it etiologically are due to infection (e.g. gram- negative folliculitis) or unknown causes (e.g. acne necrotica or acne aestivalis). oooooooooooooooooooo Introduction matory (acne medicamentosa) [1]. The diagnosis of an ac- neiform eruption should be considered if the lesions are The term ‘acneiform’ refers to conditions which super- seen in an unusual localization for acne, e.g. involvement of ficially resemble acne vulgaris but are not thought to be re- distal parts of the extremities (table 1). In contrast to acne lated to it etiologically. vulgaris, which always begins with faulty keratinization Acneiform eruptions are follicular reactions beginning in the infundibula (microcomedones), comedones are usu- with an inflammatory lesion, usually a papule or pustule.
    [Show full text]
  • Hidradenitis Suppurativa (Acne Inversa): Management of a Recalcitrant Disease
    STATE-OF-THE-ART REVIEW Editor: Bernard A. Cohen, M.D. Pediatric Dermatology Vol. 24 No. 5 465–473, 2007 Hidradenitis Suppurativa (Acne inversa): Management of a Recalcitrant Disease Joseph Lam, M.D.,* Andrew C. Krakowski, M.D.,* and Sheila F. Friedlander, M.D. *Rady Children’s Hospital, University of California, Departments of Pediatrics and Medicine (Dermatology), San Diego School of Medicine, University of California, San Diego, California Abstract: Hidradenitis suppurativa is a chronic relapsing disorder of follicular occlusion that is often recalcitrant to therapy. Topical and systemic antibiotics, hormonal therapies, oral retinoids, immunosuppressant agents, and surgical treatment are some of the therapeutic alternatives used for this often recalcitrant and frequently troublesome disorder. This article reviews the pathophysiology of hidradenitis suppurativa, an evidence-based analy- sis of standard treatments, and recent advances in the therapy of this disorder. Hidradenitis suppurativa (HS) is a disease of the (2,3), with the inflammation of apocrine glands that oc- apocrine gland-bearing areas of the body that commonly curs likely representing a secondary phenomenon affects the intertriginous areas. Although it may initially resulting from follicular plugging (3). It is now believed present in a mild form, recurrent abscesses with the that HS is primarily an inflammatory disorder of the hair development of sinus tracts and scarring generally en- follicle and, therefore, is included in the follicular occlu- sues. Rather than a distinct disease entity, it may repre- sion tetrad along with acne conglobata, dissecting cellu- sent the severe end of a spectrum of disease that includes litis, and pilonidal sinuses (4) (Table 1).
    [Show full text]